Literature DB >> 18785170

Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium.

Christine L Mummery1, Dorien Ward, Robert Passier.   

Abstract

Many of the applications envisaged for human embryonic stem cells (hESC) undergoing cardiomyogenesis require that the differentiation procedure is robust and high yield. For many hESC lines currently available this is a challenge; beating areas are often obtained but subsequent analysis shows only few (<1%) cardiomyocytes actually present. Here the authors provide a protocol based on serum-free coculture with a mouse endoderm-like cell line (END2), which yields cultures containing on average 25% cardiomyocytes for two widely available hESC lines, hES2 and hES3. The authors also provide a variant on the protocol based on growth of hESC aggregates/embryoid bodies in END2-conditioned medium and a method for dissociating beating aggregates without compromising cardiomyocyte viability so that they can be used for transplantation into animals or further (electrophysiological) analysis. Copyright 2007 by John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18785170     DOI: 10.1002/9780470151808.sc01f02s2

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  23 in total

1.  Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2.

Authors:  Punam Nagvenkar; Prasad Pethe; Harsha Pawani; Jyoti Telang; Neeraj Kumar; Indira Hinduja; Kusum Zaveri; Deepa Bhartiya
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

Review 2.  Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.

Authors:  Fabian Zanella; Robert C Lyon; Farah Sheikh
Journal:  Trends Cardiovasc Med       Date:  2013-09-17       Impact factor: 6.677

Review 3.  Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.

Authors:  Christine L Mummery; Jianhua Zhang; Elizabeth S Ng; David A Elliott; Andrew G Elefanty; Timothy J Kamp
Journal:  Circ Res       Date:  2012-07-20       Impact factor: 17.367

4.  Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes.

Authors:  A Görbe; Z V Varga; J Pálóczi; S Rungarunlert; N Klincumhom; M K Pirity; R Madonna; T Eschenhagen; A Dinnyés; T Csont; P Ferdinandy
Journal:  Mol Biotechnol       Date:  2014-03       Impact factor: 2.695

5.  Ouabain facilitates cardiac differentiation of mouse embryonic stem cells through ERK1/2 pathway.

Authors:  Yee-ki Lee; Kwong-man Ng; Wing-hon Lai; Cornelia Man; Deborah K Lieu; Chu-pak Lau; Hung-fat Tse; Chung-wah Siu
Journal:  Acta Pharmacol Sin       Date:  2010-12-13       Impact factor: 6.150

6.  Reporter-based isolation of induced pluripotent stem cell- and embryonic stem cell-derived cardiac progenitors reveals limited gene expression variance.

Authors:  Linda W van Laake; Li Qian; Paul Cheng; Yu Huang; Edward C Hsiao; Bruce R Conklin; Deepak Srivastava
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

7.  Differentiation of human ES cell line KIND-2 to yield tripotent cardiovascular progenitors.

Authors:  Harsha Pawani; Punam Nagvenkar; Prasad Pethe; Deepa Bhartiya
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-01-04       Impact factor: 2.416

8.  Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

Authors:  Katherine L Hill; Petra Obrtlikova; Diego F Alvarez; Judy A King; Susan A Keirstead; Jeremy R Allred; Dan S Kaufman
Journal:  Exp Hematol       Date:  2010-01-11       Impact factor: 3.084

Review 9.  Trends in cardiovascular engineering: organizing the human heart.

Authors:  Nathaniel L Tulloch; Charles E Murry
Journal:  Trends Cardiovasc Med       Date:  2013-05-27       Impact factor: 6.677

Review 10.  Deconstructing stem cell population heterogeneity: single-cell analysis and modeling approaches.

Authors:  Jincheng Wu; Emmanuel S Tzanakakis
Journal:  Biotechnol Adv       Date:  2013-09-11       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.